𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

✍ Scribed by Taylor, Kathleen A.; Saag, Kenneth G.; Shane, Elizabeth; Boonen, Steven; Donley, David W.; Marin, Fernando; Warner, Margaret R.; Dalsky, Gail P.; Marcus, Robert

Book ID
123124558
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
87 KB
Volume
10
Category
Article
ISSN
1094-6950

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of teriparatide versus alendrona
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six–month results of a randomized, double-blind, controlled trial
✍ Kenneth G. Saag; Jose R. Zanchetta; Jean-Pierre Devogelaer; Robert A. Adler; Ric πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Objective To compare the bone anabolic drug teriparatide (20 ΞΌg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP). ## Methods This was a 36‐month, randomized, double‐blind, controlled trial in 428 subjects with OP (ages